MedTrace Logo

Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)

NCT03600038 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2019-12-09

No results posted yet for this study

Summary

The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.

Conditions

Interventions

BEHAVIORAL

Experimental smoking cessation smartphone app

The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.

BEHAVIORAL

Standard of care smoking cessation smartphone app

The control intervention uses a standard of care smartphone smoking cessation app.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • CVS Health Foundation

    collaborator UNKNOWN

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Jonathan Bricker · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-02
Primary Completion
2019-07-31
Completion
2019-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600038 on ClinicalTrials.gov